Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings, Inc. records an AlphaScore of 51/100 in the Healthcare sector as of October 11, 2026. Key metrics feature a gross margin of 69.71% and a debt-to-equity ratio of 0.59. A key strength is the high gross margin, demonstrating strong pricing power on products. A primary risk is reflected in the return on equity, which is limited to 5.55% according to the snapshot metrics.

Written 11/10/2026, 00:32:29 UTC · Snapshot 11/10/2026